Tetracyclines in malaria
Open Access
- 10 November 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 14 (1), 1-10
- https://doi.org/10.1186/s12936-015-0980-0
Abstract
Malaria, a parasite vector-borne disease, is one of the greatest health threats in tropical regions, despite the availability of malaria chemoprophylaxis. The emergence and rapid extension of Plasmodium falciparum resistance to various anti-malarial drugs has gradually limited the number of potential malaria therapeutics available to clinicians. In this context, doxycycline, a synthetically derived tetracycline, constitutes an interesting alternative for malaria treatment and prophylaxis. Doxycycline is a slow-acting blood schizontocidal agent that is highly effective at preventing malaria. In areas with chloroquine and multidrug-resistant P. falciparum parasites, doxycycline has already been successfully used in combination with quinine to treat malaria, and it has been proven to be effective and well-tolerated. Although not recommended for pregnant women and children younger than 8 years of age, severe adverse effects are rarely reported. In addition, resistance to doxycycline is rarely described. Prophylactic and clinical failures of doxycycline have been associated with both inadequate doses and poor patient compliance. The effects of tetracyclines on parasites are not completely understood. A better comprehension of the mechanisms underlying drug resistance would facilitate the identification of molecular markers of resistance to predict and survey the emergence of resistance.Keywords
This publication has 129 references indexed in Scilit:
- Staphylococcus aureus colonization of healthy military service members in the United States and AfghanistanBMC Infectious Diseases, 2013
- Multiple populations of artemisinin-resistant Plasmodium falciparum in CambodiaNature Genetics, 2013
- Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers studyMalaria Journal, 2013
- Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and AfghanistanBMC Infectious Diseases, 2013
- Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugsMalaria Journal, 2011
- Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugsMalaria Journal, 2011
- Reliability of Antimalarial Sensitivity Tests Depends on Drug Mechanisms of ActionJournal of Clinical Microbiology, 2010
- Multinormal In Vitro Distribution Model Suitable for the Distribution of Plasmodium falciparum Chemosusceptibility to DoxycyclineAntimicrobial Agents and Chemotherapy, 2009
- In Vitro Monitoring of Plasmodium falciparum Drug Resistance in French Guiana: a Synopsis of Continuous Assessment from 1994 to 2005Antimicrobial Agents and Chemotherapy, 2008
- Tetracyclines Specifically Target the Apicoplast of the Malaria Parasite Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2006